To further evaluate the role of lowering cholesterol levels in CNS autoimmunity, we asked whether anti-PCSK9 could alter immune cell activation in the periphery despite the absence of differences in the clinical scores. This evidence concerns the gene PCSK9 and Autoimmunity.